William Nichols

Chief Tech/Sci/R&D Officer at CANDEL THERAPEUTICS, INC.

Net worth: 547 136 $ as of 30/05/2024

55 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Michael Andriole	M	51	CHIMERIX, INC.	5 years
Michael Sherman	M	58	CHIMERIX, INC.	5 years
Estuardo Aguilar-Cordova	M	66	CANDEL THERAPEUTICS, INC.	22 years
Paul-Peter Tak	M	64	CANDEL THERAPEUTICS, INC.	4 years
Paul Manning	M	68	CANDEL THERAPEUTICS, INC.	6 years
Fred Middleton	M	74	CHIMERIX, INC.	6 years
Nicoletta Loggia	M	56	CANDEL THERAPEUTICS, INC.	1 years
Christopher Martell	M	45	CANDEL THERAPEUTICS, INC.	6 years
Diem Nguyen	M	52	CANDEL THERAPEUTICS, INC.	3 years
Renee Gaeta	F	43	CANDEL THERAPEUTICS, INC.	2 years
Robert Meyer	M	65	CHIMERIX, INC.	6 years
Joseph Papa	M	68	CANDEL THERAPEUTICS, INC.	2 years
Gary Nabel	M	70	CANDEL THERAPEUTICS, INC.	2 years
Pratik Multani	M	57	CHIMERIX, INC.	4 years
Edward Benz	M	78	CANDEL THERAPEUTICS, INC.	7 years
Charles Schoch	M	39	CANDEL THERAPEUTICS, INC.	-
Odin Naderer	M	-	CHIMERIX, INC.	10 years
Nathan Caffo	M	55	CANDEL THERAPEUTICS, INC.	4 years
Caryn Barnett	F	-	CHIMERIX, INC.	4 years
Susan Stewart	F	64	CANDEL THERAPEUTICS, INC.	4 years
Francesca Barone	M	47	CANDEL THERAPEUTICS, INC.	4 years
Seshu Tyagarajan	M	57	CANDEL THERAPEUTICS, INC.	2 years
Ileen B. Winick	F	-	CANDEL THERAPEUTICS, INC.	3 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Timothy J. Wollaeger	M	80	CHIMERIX, INC.	16 years
M. Berrey	M	57	CHIMERIX, INC.	7 years
James Niedel	M	79	CHIMERIX, INC.	7 years
Joseph T. Schepers	M	65	CHIMERIX, INC.	3 years
Jason Amello	M	55	CANDEL THERAPEUTICS, INC.	2 years
James Daly	M	62	CHIMERIX, INC.	6 years
Edward F. Greissing	M	73	CHIMERIX, INC.	3 years
John Leonard	M	66	CHIMERIX, INC.	4 years
Timothy Trost	M	66	CHIMERIX, INC.	7 years
Ronald Renaud	M	55	CHIMERIX, INC.	6 years
John J. Canepa	M	68	CANDEL THERAPEUTICS, INC.	2 years
Michael D. Rogers	M	68	CHIMERIX, INC.	3 years
Linda M. Richardson	F	60	CHIMERIX, INC.	5 years
Essy Mozaffari	M	-	CHIMERIX, INC.	-
Peter N. Payne	M	64	CHIMERIX, INC.	2 years
Roberto Guzman	M	-	CHIMERIX, INC.	-
Michelle L. Rose	M	-	CHIMERIX, INC.	8 years
Kevin Reeves	M	-	CHIMERIX, INC.	-
Andrew Barrett	M	-	CHIMERIX, INC.	1 years
Heather Knight	M	-	CHIMERIX, INC.	-
Christopher Jon Matheny	M	52	CANDEL THERAPEUTICS, INC.	2 years
Brian Guzik	M	-	CANDEL THERAPEUTICS, INC.	14 years
Shannon Morris	M	54	Istari Oncology, Inc. Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC.	2 years

Statistics

Country	Connections	% of total
United States	46	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections